Sincerely appreciate the response sir. I am relieved they addressed the FDA’s 2021 “observations” from the last Audit/Inspection. Apropos the most recent “findings”, it sounds like paying more attention to details would benefit RVNC by their Quality, Ops and Management teams. Hanging on tight while this story continues it’s crazy journey forward. GLTA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.